Insuman Comb 15 Solostar

Insulin human, the active ingredient in Insuman Comb 15 Solostar, is an insulin presented as an injectable solution for subcutaneous administration. It is used to control blood glucose levels in patients with type 1 and type 2 diabetes mellitus, as part of a comprehensive diabetes management plan.

GNH USA supplies Insuman Comb 15 Solostar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to essential insulin therapy for healthcare providers and patients across multiple markets.

Insuman Comb 15 Solostar, a human insulin, acts on the insulin signaling pathway to regulate glucose metabolism and maintain stable blood sugar levels in diabetic patients.

- Type 1 diabetes mellitus: improves basal and prandial glucose control to achieve target HbA1c. - Type 2 diabetes mellitus: assists in reaching glycemic goals when combined with oral agents or lifestyle measures. - Diabetic ketoacidosis: provides basal insulin coverage during acute treatment. - Post‑operative hyperglycemia: helps maintain glucose control after surgical procedures. - Gestational diabetes mellitus: may be used under specialist supervision when insulin therapy is required.

Common Side Effects: - Hypoglycemia: symptoms may include sweating, tremor, and confusion. - Injection site reactions: redness, swelling, or itching at the injection site. - Weight gain: increased caloric storage due to improved glucose utilization. - Lipodystrophy: localized fat accumulation or loss at repeated injection sites. - Edema: mild peripheral swelling, especially in the lower extremities. - Headache: transient mild headache after injection.

Serious or Rare Side Effects: - Severe hypoglycemia leading to seizures or loss of consciousness. - Anaphylactic reaction: rash, bronchospasm, or angioedema requiring emergency care. - Insulin edema causing cardiac decompensation in susceptible patients. - Persistent hypokalemia: low potassium levels that may affect cardiac rhythm. - Necrotizing fasciitis at injection site (extremely rare). - Acute allergic bronchospasm in patients with insulin allergy.

When using Insuman Comb 15 Solostar, consider the following precautions: - Dose adjustment: tailor the insulin dose based on regular blood glucose monitoring and individual response. - Hypoglycemia risk: educate patients to recognize early symptoms and have fast‑acting carbohydrates available. - Renal impairment: monitor kidney function and adjust dosage as reduced clearance may increase hypoglycemia risk. - Pregnancy: use only if the potential benefit outweighs the potential risk to the fetus. - Drug interactions: review all concomitant medications for possible additive glucose‑lowering effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake the vial.

Insuman Comb 15 Solostar may interact with several medications. Review the following interaction categories:

Major Interactions (Avoid): - Sulfonylureas: combined use can cause severe hypoglycemia. - Beta‑blockers: may mask typical hypoglycemia warning signs. - MAO inhibitors: unpredictable alterations in glucose metabolism.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may potentiate insulin’s glucose‑lowering effect. - Thiazide diuretics: can increase blood glucose levels, requiring dose adjustment. - Oral contraceptives: may alter insulin requirements and affect glycemic control.